AI + blood test could sharpen lung cancer screening for smokers
NCT ID NCT06320184
First seen Apr 06, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study is testing whether artificial intelligence (AI) can combine blood biomarkers and CT scan images to more accurately predict lung cancer risk in heavy smokers. Researchers will analyze data from 650 current or former heavy smokers to see if these tools can better identify who is at high risk and reduce unnecessary follow-ups for benign nodules. The goal is to improve lung cancer screening programs and ultimately save lives.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, 20133, Italy
Conditions
Explore the condition pages connected to this study.